Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | EGLN1 | Q9GZT9 | 7/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.50 |
| ▸ | KDM4A | O75164 | 2/20 | 0.50 |
| ▸ | KDM6B | O15054 | 1/20 | 0.50 |
| ▸ | KDM6A | O15550 | 1/20 | 0.50 |
| ▸ | TET3 | O43151 | 1/20 | 0.50 |
| ▸ | KDM4B | O94953 | 1/20 | 0.50 |
| ▸ | KDM5C | P41229 | 1/20 | 0.50 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.50 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.50 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.50 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.50 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.50 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.50 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.50 |
| ▸ | KDM3A | Q9Y4C1 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11567115 | 0.98 | ALDH1A1 (0.57) | ALDH1A1EGLN1KDM4EL3MBTL1KDM4A | |
| SCHEMBL12564546 | 0.88 | ALDH1A1 (0.45) | ALDH1A1EGLN1KDM4EL3MBTL1KDM4A | |
| SCHEMBL10877533 | 0.85 | ALDH1A1 (0.45) | ALDH1A1EGLN1KDM4EL3MBTL1KDM4A | |
| SCHEMBL10877535 | 0.85 | PARP1 (0.51) | ALDH1A1EGLN1KDM4EL3MBTL1KDM4A | |
| SCHEMBL11729968 | 0.85 | ALDH1A1 (0.45) | ALDH1A1EGLN1KDM4EL3MBTL1KDM4A | |
| SCHEMBL9872674 | 0.84 | ALDH1A1 (0.45) | ALDH1A1EGLN1LMNAALOX12CYP3A4 | |
| Hydrochloric Acid SCHEMBL11567111 | 0.83 | ALDH1A1 (0.44) | ALDH1A1EGLN1KDM4EL3MBTL1KDM4A | |
| SCHEMBL29532238 | 0.81 | KDM4E (0.48) | ALDH1A1EGLN1KDM4EL3MBTL1KDM4A | |
| SCHEMBL5259859 | 0.81 | NAPRT (0.51) | ALDH1A1EGLN1KDM4EL3MBTL1KDM4A | |
| SCHEMBL15738360 | 0.81 | KDM4E (0.46) | ALDH1A1EGLN1KDM4EL3MBTL1KDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117684330-A | Elastic felt for deep cooling | 威伦维客节能科技(安徽)有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-109223779-A | A kind of pharmaceutical composition and its preparation method and application promoting union | 苏涛 | 2019-01-18 | — | — | CN | claimed |
| CN-117684330-A | Elastic felt for deep cooling | 威伦维客节能科技(安徽)有限公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-117684330-A | Elastic felt for deep cooling | 威伦维客节能科技(安徽)有限公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-109223779-A | A kind of pharmaceutical composition and its preparation method and application promoting union | 苏涛 | 2019-01-18 | — | — | CN | disclosed |
| EP-2181996-A1 | Aminopiperidine derivatives | GLAXO GROUP LIMITED (GB) | 2010-05-05 | — | — | EP | disclosed |
| US-20100081650-A1 | Antimicrobial Compounds | AXTEN JEFFREY MICHAEL | 2010-04-01 | — | — | US | disclosed |
| US-7622481-B2 | Antibacterial compounds | GLAXO GROUP LIMITED (GB) | 2009-11-24 | — | — | US | disclosed |
| US-7534793-B2 | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity | SMITHKLINE BEECHAM P.L.C. (GB) | 2009-05-19 | — | — | US | disclosed |
| EP-1537123-B1 | AMINO-SUBSTITUTED CYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS | GLAXO GROUP LTD (GB) | 2009-04-29 | — | — | EP | disclosed |
| US-7498326-B2 | Compounds | GLAXO GROUP LIMITED (GB) | 2009-03-03 | — | — | US | disclosed |
| US-4198504-A | ANTIBIOTIC | BRISTOL-MYERS COMPANY (US) | 1980-04-15 | — | — | US | disclosed |
| EP-0006688-A1 | Dimethyl sulfoxide adducts of sodium 6-(D(-)-alpha-(4-hydroxy-1,5-naphthyridine-3-carboxamido)phenylacetamido)penicillanate or the derivative thereof bearing a hydroxyl group at the p-position of the phenyl group, methods for their preparation and decomposition, and their use as intermediates for purifying the crude penicillins | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-01-09 | — | — | EP | disclosed |
| US-4138554-A | 7-[D-α-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-α-phenyl (and p-hydroxyphenyl)acetamido]-3-carbamoyloxymethyl-3-cephem-4-carboxylic acids | BRISTOL-MYERS COMPANY (US) | 1979-02-06 | — | — | US | disclosed |
| US-4026881-A | 6-(D-2-[4-hydroxy-1,5-naphthyridine-3-carboxamido]-2-[4-hydroxyphenyl]acetamido)-2,2-dimethyl-3-(5-tetrazolyl)penam | PFIZER INC. (US) | 1977-05-31 | — | — | US | disclosed |
| US-4005075-A | Penicillins and their preparation | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-01-25 | — | — | US | disclosed |
| US-4003887-A | ANTIMICROBIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-01-18 | — | — | US | disclosed |
| US-3992371-A | BACTERICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-11-16 | — | — | US | disclosed |
| US-3954733-A | ANTIBIOTIC | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-05-04 | — | — | US | disclosed |
| US-3945995-A | ANTIBIOTICS, PENICILLIN | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081650-A1 | Antimicrobial Compounds | ELANE, NISCH, PIGS | ALDH1A1 2504/4885EGLN1 103/4885KDM4E 4273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.